Clinical Trials Browser

Approved for marketing × motexafin gadolinium × Clear all

NCT04809584 2024-12-19

18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer

Approved for marketing

Prostatic Neoplasms